Ethyl (3R,4R,5S)-4-(acetyl(tert-butyl)amino)-5-(di(prop-2-en-1-yl)amino)-3-((pentan-3-yl)oxy)cyclohex-1-ene-1-carboxylate–hydrogen chloride (1/1)

Involved in the development of antiviral drug candidates, particularly neuraminidase inhibitor–related compounds. Applied in stereoselective medicinal chemistry synthesis. Useful for structure–activity relationship (SAR) studies during drug optimization. Ethyl (3R,4R,5S)-4-(acetyl(tert-butyl)amino)-5-(di(prop-2-en-1-yl)amino)-3-((pentan-3-yl)oxy)cyclohex-1-ene-1-carboxylate · HCl (1:1): Used as a key synthetic intermediate in pharmaceutical manufacturing.